Weight loss drugs out of reach, Medicare won't pay | News, Sports, Jobs
WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions
Stay updated with breaking news from Mark Mcclellan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions
WASHINGTON (AP) -- New obesity drugs are showing promising results in helping some people shed pounds, but the injections will remain out of reach for millions of older Americans because Medicare is forbidden to cover such medications.
Despite its ban, the supplement androstenedione, or “andro,” is known for its many side effects. Androstenedione is a banned supplement, but that doesn't mean it's not still being used. Learn more about andro, including what it is, how it acts in the body and its dangerous side effects.
WASHINGTON (AP) — New obesity drugs are showing promising results in helping some people shed pounds but the injections will remain out of reach for millions
Obesity drugs like Wegovy and Zepbound are capturing the attention of celebrities and showing promising results in helping people shed pounds. But those drugs remain out of reach for millions